Abstract-Depressed contractility is a central feature of the failing human heart and has been attributed to altered [Ca 2ϩ ] i . This study examined the respective roles of the L-type Ca 2ϩ current (I Ca ), SR Ca 2ϩ uptake, storage and release, Ca 2ϩ transport via the Na ϩ -Ca 2ϩ exchanger (NCX), and Ca 2ϩ buffering in the altered Ca 2ϩ transients of failing human ventricular myocytes. Electrophysiological techniques were used to measure and control V m and measure I m , respectively, and Fluo-3 was used to measure [Ca 2ϩ ] i in myocytes from nonfailing (NF) and failing (F) human hearts. Ca 2ϩ transients from F myocytes were significantly smaller and decayed more slowly than those from NF hearts. Ca 2ϩ uptake rates by the SR and the amount of Ca 2ϩ stored in the SR were significantly reduced in F myocytes. There were no significant changes in the rate of Ca 2ϩ removal from F myocytes by the NCX, in the density of NCX current as a function of [ Key Words: excitation-contraction coupling Ⅲ sarcoplasmic reticulum Ⅲ Na ϩ -Ca 2ϩ exchanger Ⅲ congestive heart failure C ongestive heart failure (HF) is the leading cause of death in Western civilization. 1 Although this syndrome has many different and distinct causes, all forms share a number of common features, which include prolongation of the QT interval, 2, 3 progressive depression of basal cardiac contractility, 4, 5 and loss of inotropic reserve. 6 Whereas these changes in the physiological properties of the heart have been described in HF animal models 7 and in failing human hearts, muscle strips, 8 and isolated myocytes, 9 their cellular basis is still not well understood and is the topic of this article.
Contraction of human cardiac myocytes is a Ca 2ϩ -dependent process. During diastole, the intracellular [Ca 2ϩ ] i is maintained at sufficiently low levels to prevent activation of contractile proteins. 10 With each heartbeat, Ca 2ϩ influx via the L-type Ca 2ϩ channel triggers release of Ca 2ϩ from the sarcoplasmic reticulum (SR). 11 These two sources combine to elevate [Ca 2ϩ ] i , which promotes Ca 2ϩ binding to troponin and activation of the contractile process. Contraction is terminated as Ca 2ϩ is transported back into the SR by the SR Ca 2ϩ -ATPase (SERCA) and out of the cell via the sarcolemmal Na ϩ -Ca 2ϩ exchanger (NCX). 10 The rate, intensity, and duration of contraction are largely determined by the amount of Ca 2ϩ delivered to the cytoplasm, the Ca 2ϩ binding properties of troponin and other Ca 2ϩ binding proteins, 12 and the rate of Ca 2ϩ removal from the cytoplasm by the SR and from the cell via the NCX. 10 The depressed contractility of the failing heart is thought to involve alterations in myocyte Ca 2ϩ regulation 8 and the isoforms and regulation of thin and thick filament contractile proteins. 13 This article will focus on the role of altered Ca 2ϩ regulation in the depressed contractility of the failing human ventricular myocyte. Only two studies 14, 15 have shown alterations in the amplitude and duration of the Ca 2ϩ transients of failing myocytes, and these have not established the underlying cellular basis. Alterations in SERCA mRNA, protein, or function have been reported, but these SERCA changes have not been uniformly observed or well characterized in isolated myocytes. 8 Significant abnormalities in EC coupling, in the properties of SR Ca 2ϩ release channels (ryanodine receptors, RYR) 16 or in NCX abundance have also been reported. 8 These findings suggest that whereas dysregulated myocyte Ca 2ϩ may be a common feature of HF, the cellular basis may be highly variable. This could reflect fundamental speciesspecific differences in Ca 2ϩ regulation 10 and the complex interaction of different Ca 2ϩ regulatory processes in a given species. 7 The objective of this study was to perform an in-depth evaluation of Ca 2ϩ regulatory processes in nonfailing (NF) and failing (F) human ventricular myocytes to determine the cellular basis of deranged Ca 2ϩ transients in HF. Myocytes were isolated from F and NF human hearts as described previously. 17 Membrane voltage and current were controlled and recorded using discontinuous, single-electrode voltage clamp techniques, respectively. 18 pClamp8 software (Axon Instruments) was used to control the patch clamp amplifier. [Ca 2ϩ ] i was measured with fluo-3 (K salt) loaded through patch pipettes. A typical AP, recorded in current clamp with physiological solutions at 1 Hz from a F human myocyte and 37°C, was used as a template for AP clamp. Myocytes were conditioned with ten 500-ms square wave voltage steps to ϩ30 mV. SR Ca 2ϩ content was assessed with rapid application of 10 mmol/L caffeine (10 seconds) in place of an AP clamp (1 Hz, E hold ϭϪ70 mV). 19 All measurements were at 37°C.
An expanded Materials and Methods section can be found in the online data supplement available at http://www.circresaha.org.
Results

Patient Characteristics
Eleven F hearts were obtained at the time of transplantation, and 7 NF hearts that were unsuitable for transplantation were studied. In the F group, 5 had ischemic heart disease and 6 had idiopathic/nonischemic dilated cardiomyopathies. Other patient characteristics are listed in Table 1 .
Action Potential and Contractions
AP and contraction durations were longer in F versus NF myocytes paced at 0.5 Hz (Figure 1 ). The amplitude of contraction was also smaller in F versus NF, but these differences were not statistically significant. These results confirm those we have reported previously 15 ( Figure 2C ). 20 21 ) was not significantly different in NF and F myocytes ( Figure 2F ). This is consistent with the notion that a lower SR Ca 2ϩ load is the primary cause of the reduced Ca 2ϩ transient amplitude in F. In vivo the AP duration (QT interval) is prolonged in the failing heart by 15 to 40 ms (dependent on heart rate). 2 This would tend to increase Ca 2ϩ influx and SR Ca 2ϩ loading and limit the difference between F and NF myocytes (versus our case where AP clamps were identical). In separate controls, we found that prolonging depolarization by 120 ms increased SR Ca 2ϩ load by 34%, but was still less than NF myocytes. Smaller, more physiological prolongations of depolarization (30 ms) did not significantly alter SR Ca 2ϩ load. Thus, even with in vivo APs the SR Ca 2ϩ content would be significantly smaller in F versus NF myocytes.
In principle, reduced L-type Ca 2ϩ current (I Ca,L ) as a trigger could also cause reduced Ca 2ϩ transient in F myocytes. In experiments where I Ca,L was studied with other currents blocked ( Figure 3 ), I Ca,L density was not significantly different in F versus NF myocytes, particularly at positive voltages associated with the peak and plateau phase of the AP. There was a negative shift in the E m dependence of I Ca,L activation in F myocytes (Figure 3 ), but this cannot account for the depressed Ca 2ϩ transient observed in F myocytes in the present experiments. These findings do not rule out a role for altered Ca 2ϩ influx via the L-type Ca 2ϩ channel during increases in heart rate 22 or secondary to changes in shape of early portions of the AP 23 in the failing heart.
Contributions of SR Ca 2؉ -ATPase and NCX to [Ca 2؉ ] i Decline
The function and competition between the SR Ca 2ϩ -ATPase and NCX can be assessed by analyzing the rate of [Ca 2ϩ ] i decline during twitch and caffeine-induced Ca 2ϩ transients. 24 The rate constant of [Ca 2ϩ ] i decline during a caffeine-induced Ca 2ϩ transient largely reflects the function of NCX (k NCX ), and this was not different between F and NF myocytes ( Figure  4A , Table 2 ). Thus, the intrinsic Ca 2ϩ extrusion activity of NCX seems unaltered in the F myocytes studied here. Both NCX and the SR Ca 2ϩ -ATPase contribute to twitch [Ca 2ϩ ] i decline, and the rate constant (k Twitch ) is significantly slower in F myocytes ( Figure 4A , Table 2 ). The difference between k Twitch and k NCX can be taken as the rate constant of twitch [Ca 2ϩ ] i decline attributable to the SR Ca 2ϩ -ATPase (k SR ). In F myocytes, this rate was only 57% of that in NF myocytes ( Figure 4A , Table 2 
NCX Surface:Volume Ratio and Ca 2؉ Buffering
The analysis above suggests that NCX Ca 2ϩ extrusion properties are unchanged in F myocytes (based on [Ca 2ϩ ] i decline). We also assessed NCX function directly as I NCX . Figure 5A shows that inward I NCX density as a function of [Ca 2ϩ ] i (at E m ϭϪ70 mV) was not significantly different in F versus NF myocytes. This confirms that NCX characteristics are unaltered in F human ventricular myocytes.
NCX function was unchanged whether measured as a function of cytosolic volume (⌬ [Ca 2ϩ ] i in mol/L cytosol) or surface area (I NCX in A/F). This suggests that there is no major change in the surface to volume ratio in F myocytes. Indeed, the 64% increase in surface area in F versus NF based on cell capacitance (Table 2 ) is comparable to the increase in cell volume that we previously measured by flow cytometry (85%), albeit from different hearts. 25 Because the surface:volume of a cylinder decreases with increasing size, there must be increased membrane area in transverse tubules (or other infoldings) to maintain total surface:volume relatively unchanged (see online data supplement). We also measured cytosolic Ca 2ϩ buffering as described by Trafford et al. 26 This is essentially a back-titration using [ influx (especially when there is a slowly rising phase as in Figure 2A ). To explore whether NCX may contribute to the slow [Ca 2ϩ ] i decline in F myocytes, we measured the E m dependence of [Ca 2ϩ ] i late in the AP using a two-step protocol ( Figure 6B ). After 5 conditioning beats, an E m step to ϩ10 mV initiated Ca 
Discussion
Alterations in the size and shape of the systolic Ca 2ϩ transient are characteristic phenotypic alterations of the failing human ventricular myocyte. 15 In the present experiments, we studied the cellular basis of these altered Ca 2ϩ transients. Our major findings are as follows: (1) 
Ca
2؉ Handling in the Failing Human Heart
Depressed cardiac contractility and diminished contractility reserve are important phenotypic abnormalities of the failing human heart that have been appreciated for more than 100 years. In the past two decades, it has been shown that alterations in myocyte Ca 2ϩ regulation are centrally involved in deranged contractility but the cellular bases have not been well established, in large part because it is difficult to obtain high-quality human heart tissue for thorough in vitro evaluation. Although some aspects of Ca 2ϩ regulation have been examined in F human myocytes, to our knowledge, ours is the first in which there has been an in-depth evaluation of the respective contributions of SR, NCX, Ca 2ϩ buffers, and I Ca,L to defective Ca 2ϩ regulation. Our results, consistent with results of others, 14, 27 point to abnormal SR function as the primary basis for the deranged Ca 2ϩ transients we observed in human F myocytes. Depressed SR function would account for the slow rate of decay of the Ca 2ϩ transient and the reductions in SR Ca 2ϩ storage and release that reduce the magnitude of the Ca 2ϩ transient. The molecular bases for depressed SR function in F human myocytes was not examined in these experiments but has been studied before by us (in tissue samples from the same hearts used to obtain the isolated myocytes used in the present study) 15 and others. 8 Our previous study showed a smaller SERCA protein and no difference in the NCX protein abundance in NF versus F hearts. 15 These molecular measurements correlate well with the biophysical assessments of 
Ca
2ϩ regulation reported in the present study. Reduction in the abundance of SERCA protein, increased abundance of phospholamban (PLB), decreased PLB phosphorylation, and an increased rate of Ca 2ϩ leak from the SR have all been described in the failing human heart by others and may all play some role. 7, 8, 15, 28 Future studies will need to focus on the respective quantitative contribution of each of these changes to depressed SR function. The most important point here is that slower SR Ca 2ϩ transport is not exclusively dependent on a reduced abundance of SERCA protein, but could also result from altered SERCA regulation via PLB 29 or because of an increased leak rate, eg, through a hyperphosphorylated Ca 2ϩ release channel. 30 The reduced SR Ca 2ϩ content in HF is consistent with data in human, rabbit, and canine HF models. 27, 31, 32 In the rabbit HF model, SR Ca 2ϩ content was reduced by a combination of large increase in NCX function and a modest decrease in SR Ca 2ϩ -ATPase function (the canine model was similar 33 ). Both of these changes unload the SR and depress systolic function, but they can be offsetting in terms of relaxation and diastolic function. Similar detailed analysis has not previously been done in human HF, but work from Hasenfuss and coworkers 34, 35 suggested a similar combination of enhanced NCX and reduced SR Ca 2ϩ -ATPase function. Moreover, in one subset of human HF (with relatively preserved diastolic function), they found greatly enhanced NCX expression and modestly reduced SR Ca 2ϩ -ATPase expression, functionally like the rabbit HF model described earlier. However, another group had no significant increase in NCX, marked downregulation of SR Ca 2ϩ -ATPase expression, and slower relaxation (resembling the ensemble human HF myocytes studied here). Importantly, we found some heart to heart heterogeneity, but there was no clear segregation of phenotypes. The reason for the difference in human HF phenotype between these studies is not clear. We speculate that the failing human hearts studied here are at a more uniformly advanced stage of HF (evidenced by the mean ejection fraction of 17.5% versus 24.2% 34 ). We hypothesize that there is an increase in the abundance of NCX in earlier, more compensated forms of heart failure, and that a shift from a high NCX expression (with modest SR Ca 2ϩ -ATPase decrease) to marked downregulation of SR Ca 2ϩ -ATPase function (with NCX returning to nearly normal) is associated with HF progression.
Our results do not indicate significant intrinsic changes in EC coupling in F human myocytes (similar to the rabbit and dog studies). 31, 32 Some rat and mouse studies of hypertrophy and failure 36 found reduced ability of I Ca,L to trigger SR Ca 2ϩ release (reduced EC coupling gain), without altered SR Ca 2ϩ load. Our results show no significant alteration in I Ca,L density in F myocytes and normal fractional SR Ca 2ϩ , despite the reduced SR Ca 2ϩ loading. These finding are inconsistent with large reductions in EC coupling "gain" in human F myocytes, at least under our conditions. Whereas dysregulated Ca 2ϩ is central to depressed contractility in failing hearts of both large and small animals, the precise cellular basis for the abnormalities might differ. Given the fundamental differences in normal Ca 2ϩ regulation in large and small mammals, 10 this may not be surprising. 37, 38 and because the NCX is biased more toward reverse mode (Ca 2ϩ influx) NCX. 39 We have proposed previously 40 
Limitations
All studies that use cells and tissues from NF and F human hearts should be interpreted cautiously. Human HF is a complex syndrome and treatments are not uniformly applied. Therefore, substantial heterogeneity in myocyte properties is expected. In addition, nonfailing hearts are not necessarily representative of the normal human population. In addition, these hearts must be protected from ischemic injury. 17 In spite of these limitations, we contend that novel insights into the bases of cardiac dysfunction have been obtained in the present experiments. These insights should form the bases of new hypotheses that can be best tested in appropriate animal models of human HF.
Summary and Conclusions
The present results suggest that reduced SR Ca 2ϩ uptake, storage, and release are the primary causes of depressed contractility in failing human myocytes. These changes reduce the size of the Ca 2ϩ transient, which should promote additional Ca 2ϩ influx during the AP plateau, which would further slow the rate of Ca 2ϩ transient decay. The value of 13 pF/pL cytosol comes from direct measurements in rat ventricular myocytes (and was the same in normal and hypertrophy). 2 Note that this is related to cytosolic vs. total cell volume, i.e. corrected for the 35% of cell volume which is occupied by mitochondria etc. 3 There are no published values for human ventricular myocytes and we did not measure cell volume here. We attempted to extract some reasonable volume values from published work 4 The values obtained were 0.6-0.7 µm 2 /µm 3 , equivalent to ~10 pF/pL cytosol (assuming 35% of the cell volume is occupied by mitochondria). Thus, for the moment we consider the value we used (13 pF/pL cytosol) a useful practical estimate (e.g. between 10 and 17 pF/pL, and like rat ventricular myocytes). 
Statistical Analysis
Data are expressed as mean±SEM. Unpaired Student's t-test (or ANOVA) was used to compare F vs. NF results (p < 0.05 was considered significant).
